Your browser doesn't support javascript.
loading
Association of postoperative length of stay with outcomes following orthotopic heart transplantation-A national analysis.
Curry, Joanna; Bakhtiyar, Syed Shahyan; Kim, Shineui; Sakowitz, Sara; Verma, Arjun; Ali, Konmal; Chervu, Nikhil L; Benharash, Peyman.
Afiliação
  • Curry J; Cardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, California, USA.
  • Bakhtiyar SS; Cardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, California, USA.
  • Kim S; Department of Surgery, University of Colorado Anschutz Medical Center, Denver, Colorado, USA.
  • Sakowitz S; Cardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, California, USA.
  • Verma A; Cardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, California, USA.
  • Ali K; Cardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, California, USA.
  • Chervu NL; Cardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, California, USA.
  • Benharash P; Cardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, California, USA.
Clin Transplant ; 37(11): e15096, 2023 11.
Article em En | MEDLINE | ID: mdl-37552712
ABSTRACT

BACKGROUND:

In the absence of standardized recovery protocols, there is little evidence to guide postoperative care to ensure optimal in-hospital and long-term outcomes following heart transplantation (HT). Using two national databases, we examined the association between postoperative length of stay (LOS) with patient/graft survival, index hospitalization costs, and non-elective readmissions.

METHODS:

Adult HT recipients from 2010 to 2019 were identified and analyzed within the Organ Procurement and Transplantation Network (OPTN) Database and Nationwide Readmissions Database (NRD). The risk-adjusted relationship between 1-year mortality and LOS was assessed with restricted cubic splines and subsequently used to stratify patients into Expedited (7-11 days), Routine (12-16 days), and Delayed (>16) discharge groups. Survival outcomes were analyzed using Restricted Means Survival Time analysis (RMST) and multivariable Cox models.

RESULTS:

Of 9995 HT recipients within the OPTN, 3777 (38%) were categorized as Expedited, and 3040 (30%) as Routine. After adjustment, expedited discharge was not associated with inferior 90-day (ΔRMST -.01, p = .91) and 1-year patient survival (ΔRMST -.02, p = .53). Additionally, expedited was not associated with increased odds of non-elective readmission at 90-days (HR 1.04, CI .77-1.43) relative to Routine discharge. Counterfactual analysis revealed an estimated cost saving of $50 million if all Routine patients received an expedited discharge.

CONCLUSION:

Expedited discharge after HT seems to be cost-effective and is not associated with inferior outcomes. Institutional-level outcome analyses should be performed to identify patients that would benefit from expedited discharge, and future studies should analyze the feasibility of implementing standardized discharge protocols following HT.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Órgãos / Transplante de Coração Tipo de estudo: Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Clin Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Órgãos / Transplante de Coração Tipo de estudo: Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Clin Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos